BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 11367711)

  • 21. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?
    Tajiri J; Noguchi S
    Thyroid; 2005 Mar; 15(3):292-7. PubMed ID: 15785251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of recombinant human G-CSF in the treatment of propylthiouracil-induced agranulocytosis.
    Altunbas H; Yazicioglu G; Balci MK; Karayalçin U; Undar L
    Int J Clin Pract; 1999; 53(5):396-7. PubMed ID: 10695110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis.
    Tajiri J; Noguchi S
    Thyroid; 2004 Jun; 14(6):459-62. PubMed ID: 15242574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug therapy of Basedow's disease].
    Ishii J
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):868-72. PubMed ID: 1700042
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse effects related to antithyroid drugs and their dose regimen.
    Romaldini JH; Werner MC; Bromberg N; Werner RS
    Exp Clin Endocrinol; 1991 May; 97(2-3):261-4. PubMed ID: 1915643
    [No Abstract]   [Full Text] [Related]  

  • 26. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis--report of 11 cases.
    Li KL; Huang HS; Wang PW; Lin JD; Juang JH; Liu RT; Huang BY; Huang MJ
    Changgeng Yi Xue Za Zhi; 1991 Sep; 14(3):168-73. PubMed ID: 1718579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agranulocytosis secondary to propylthiouracil.
    Khaliq W; Ponor L; Cheripalli P; Tangella K; Chaudhry Z
    QJM; 2012 Nov; 105(11):1109-11. PubMed ID: 21920992
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithyroid drug-induced agranulocytosis: report of 13 cases.
    Huang CH; Li KL; Wu JH; Wang PN; Juang JH
    Chang Gung Med J; 2007; 30(3):242-8. PubMed ID: 17760275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of a patient with Graves' disease on hemodialysis complicated by antithyroid drug-induced granulocytopenia and angina pectoris.
    Miyasaka Y; Yoshimura M; Tabata S; Shozu A; Nishikawa M; Iwasaka T; Inada M
    Thyroid; 1997 Aug; 7(4):621-4. PubMed ID: 9292952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of drug-induced bone marrow suppression with recombinant human granulocyte/monocyte colony stimulating factor.
    Somogyi A; Rosta A; Lang I; Werling K
    Adverse Drug React Toxicol Rev; 1996 Jun; 15(2):119-24. PubMed ID: 8836317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emphasis on the early diagnosis of antithyroid drug-induced agranulocytosis: retrospective analysis over 16 years at one Chinese center.
    He Y; Li J; Zheng J; Khan Z; Qiang W; Gao F; Zhao Y; Shi B
    J Endocrinol Invest; 2017 Jul; 40(7):733-740. PubMed ID: 28236218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum concentrations of granulocyte colony-stimulating factor (G-CSF) in antithyroid drug-induced agranulocytosis.
    Murakami Y; Sasaki I; Hiraiwa T; Arishima T; Ito M; Hanafusa T; Sakane S; Ohsawa N; Takamatsu J; Miyauchi A; Kuma K
    Endocr J; 2004 Dec; 51(6):579-85. PubMed ID: 15644577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithyroid drug-induced agranulocytosis.
    Sun MT; Tsai CH; Shih KC
    J Chin Med Assoc; 2009 Aug; 72(8):438-41. PubMed ID: 19687001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithyroid drug-induced aplastic anemia.
    Thomas D; Moisidis A; Tsiakalos A; Alexandraki K; Syriou V; Kaltsas G
    Thyroid; 2008 Oct; 18(10):1043-8. PubMed ID: 18816182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
    Bukhari S; Khan M; Kumar N; Mohan V
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28716776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis.
    Yang J; Zhong J; Xiao XH; Zhou LZ; Chen YJ; Liu JH; Cao RX; Wen GB
    Endocr J; 2013; 60(2):185-9. PubMed ID: 23117149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
    Schut NH; Wiersinga WM; Van Oers MH
    Neth J Med; 1993 Aug; 43(1-2):71-3. PubMed ID: 8232698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propylthiouracil (PTU)-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factor (G-CSF).
    Balkin MS; Buchholtz M; Ortiz J; Green AJ
    Thyroid; 1993; 3(4):305-9. PubMed ID: 7509672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.